A vascular ulcer is a type of wound or sore that does not heal or returns repeatedly. Leg and foot ulcers are frequently caused by cardiovascular or other medical conditions. They can appear on the inside of your leg below the knee, the bottoms of your feet, or anywhere your feet rub together.
To treat vascular ulcers, the doctor may advise taking antibiotics or dressing, cleaning, and bandaging the wound. They may also advise to use compression therapy. This entails wrapping the affected area in a compression bandage or stocking. This pressure increases blood flow and alleviates symptoms.
Market Dynamics
Market players are focused on awareness programs related to impact of heart health on wound healing, which could contribute to the growth of the global vascular ulcers treatment market over the forecast period. For instance, on February 3, 2020, Healogics Inc., leading provider of advanced wound care services, conducted their fifth annual Heart Health Awareness campaign to bring attention to the concerns of heart health and wound healing. During Heart Health Awareness Month, members of the Healogics team collaborated to raise awareness about the impact of cardiovascular illnesses on wound healing. Also, it was explained how distinguishing between arterial and venous ulcers can be difficult, but a precise diagnosis can lead to the best treatment options.
Increasing initiatives by non-profit organizations related to diabetes is expected to strengthen their position in the global vascular ulcers treatment market. For instance, on November 14, 2018, The American Medical Association (AMA), the Centers for Disease Control and Prevention (CDC), and the Ad Council launched the "Do I Have Pre-diabetes" campaign, which features motivational messages emphasizing the prevalence of pre-diabetes in American adults. The newly updated campaign employs amusing scenarios to show viewers the many people in their lives who may have pre-diabetes and encourages them to take an easy online risk test to find out where they stand.
Market players and non-profit organizations are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, which is expected to drive the growth of the global vascular ulcers treatment market. For instance, on April 14, 2021, The Lindsay Leg Club Foundation (LLCF), a charitable foundation in the U.K., announced an innovative partnership agreement with AD INTEGRUM Vascular & Wound Care, a vascular and wound care service in England. The goal of this collaborative working partnership is to raise awareness of the fact that the two organizations are working towards the same goal: providing wound care and a better quality of life for people with lower limb conditions and leg ulcers.
Key features of the study:
- This report provides an in-depth analysis of global vascular ulcers treatment market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global vascular ulcers treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Bristol Myers Squibb Co., Sanofi, Bayer AG, Pfizer Inc., Novo Nordisk A/S, and Cadila Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global vascular ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global vascular ulcers treatment market
Detailed Segmentation:
- Global Vascular Ulcers Treatment Market, By Disease Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- Global Vascular Ulcers Treatment Market, By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory Drug (NSAID)
- Others
- Global Vascular Ulcers Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Vascular Ulcers Treatment Market, By Region:
- North America
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Latin America
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
-
- Middle East
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Treatment Type:
- Arterial Ulcers
- Venous Ulcers
- Neurotropic Ulcers
- Diabetic Ulcers
- Others
- By Drug Class:
- Antibiotics
- Hemorrheologic Agents
- Corticosteroids
- Non-steroidal Anti-inflammatory (NSAID)
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Bristol Myers Squibb Co.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- Cadila Pharmaceuticals Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
